生产和优化针对TCR-Vβ2+T细胞恶性瘤的现成免疫治疗药物
Jingjing Ren1, Xiaofeng Liao2, Julia M Lewis3
1Department of Dermatology, Yale School of Medicine, New Haven, CT, USA. jingjing.ren@yale.edu.
Nature communications
|January 15, 2024
概括
这项研究介绍了一种新型的全基化化学抗原受体 (CAR) -T疗法,针对T细胞受体Vβ链,有效地杀死恶性T细胞,同时保存健康的T细胞. 这种方法为T细胞恶性瘤提供了一个有希望的现成治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 基因治疗 基因治疗
背景情况:
- 目前的T细胞恶性瘤治疗面临的挑战是复发和非目标毒性.
- 针对克隆特异性T细胞受体 (TCR) Vβ链提供了选择性癌细胞消除的潜在策略.
研究的目的:
- 开发一种"现成"的全源化学抗原受体 (CAR) -T细胞平台,针对T细胞恶性瘤的TCR Vβ链.
- 设计专门消除恶性T细胞的CAR-T细胞,同时最大限度地减少对健康T细胞的损害.
主要方法:
- 利用CRISPR基因编辑,在健康的供体T细胞中消除TRAC,B2M和CIITA,以防止移植对宿主和宿主对移植反应.
- 通过lentivirus和adeno相关病毒转导生成了第二代4-1BB/CD3zetaCARs,具有高亲和度的人性化抗Vβ单链可变片段 (scFv).
- 开发了Fc工程的人性化抗Vβ2抗体,以增强由NK细胞介导的抗体依赖细胞细胞毒性 (ADCC).
主要成果:
- 改造的CAR-T细胞表现出高效的表达和有限的先前存在的免疫反活性.
- 卡尔-T细胞在体外和体内专门和持续地杀死Vβ2+Jurkat细胞和来自患者的恶性T细胞.
- 正常的T细胞不受CAR-T细胞治疗的影响.
结论:
- 开发的全基性CAR-T平台有效向并消除表达特定TCRVβ链的恶性T细胞.
- 这种方法显示了作为T细胞恶性瘤的"现成"治疗方法的潜力,并改善了安全性.
- Fc工程抗体为NK细胞介导的ADCC治疗T细胞恶性瘤提供了替代或补充的策略.
相关概念视频
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
Cancer Vaccines
368
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
368
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
T Cell Activation and Clonal Selection
739
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
739


